Cargando…
Aspirin as a potential modality for the chemoprevention of breast cancer: A dose-response meta-analysis of cohort studies from 857,831 participants
BACKGROUND: Previous meta-analyses on the relationship between aspirin use and breast cancer risk have drawn inconsistent results. In addition, the threshold effect of different doses, frequencies and durations of aspirin use in preventing breast cancer have yet to be established. RESULTS: The searc...
Autores principales: | Lu, Liming, Shi, Leiyu, Zeng, Jingchun, Wen, Zehuai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522308/ https://www.ncbi.nlm.nih.gov/pubmed/28418881 http://dx.doi.org/10.18632/oncotarget.16315 |
Ejemplares similares
-
Uncovering the mechanism of action of aspirin in HCC chemoprevention
por: Roehlen, Natascha, et al.
Publicado: (2019) -
Colorectal cancer chemoprevention: is aspirin still in the game?
por: Grancher, Adrien, et al.
Publicado: (2022) -
The Y831C Mutation of the POLG Gene in Dementia
por: Borgione, Eugenia, et al.
Publicado: (2023) -
Association of Long-term Use of Low-Dose Aspirin as Chemoprevention With Risk of Lung Cancer
por: Ye, Shinhee, et al.
Publicado: (2019) -
Gastroprotective [6]-Gingerol Aspirinate as a Novel Chemopreventive Prodrug of Aspirin for Colon Cancer
por: Zhu, Yingdong, et al.
Publicado: (2017)